[Retracted] A Potential Prognostic Biomarker for Glioma: Aldo-Keto Reductase Family 1 Member B1

Figure 2

The correction of AKR1B1 expression with clinicopathologic characteristics. (a) Histological type. (b) WHO grade. (c) Primary therapy outcome. (d) 1q/19q codeletion. (e) IDH status. (f) Age.

(a)

(b)

(c)

(d)

(e)

(f)